Hematology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
HEADS OF FACULTY
-
Medical Oncology/Hematologic Neoplasia , Dana-Farber Cancer Institute, Boston, MA, USA
-
Department of Hematology, Hôpital St Louis, Paris, France
LATEST RECOMMENDATION
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
1 Recommendation, most recent by
Nancy Speck and Joanna Tober, University of Pennsylvania, USA. F1000 Hematology
- New Finding
- Technical Advance
Past 7 Days
15
New Recommendations
4,458 total
11
New Articles Recommended
2,838 total
Past 30 Days
-
8Articles Classified As Good for Teaching127 total
-
3Articles Classified As Review / Commentary156 total
-
2Articles Classified As Controversial266 total
-
6Articles Classified As Technical Advance424 total
-
11Articles Classified As Confirmation931 total
-
2Articles Classified As Novel Drug Target92 total
-
1Articles Classified As Refutation45 total
-
14Articles Classified As Clinical Trial1,183 total
-
2Articles Classified As Changes Clinical Practice209 total
-
6Articles Classified As Interesting Hypothesis508 total
-
30Articles Classified As New Finding2,427 total
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
